1. World Health Organization . Fact sheet/Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed Online on the 25th June 2020.
Google Scholar2. World Health Organisation , Fact sheets/Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 09 June 2020.
Google Scholar3. Xia, C, Rao, X, Zhong, J. Role of T lymphocytes in type 2 diabetes and diabetes-associated inflammation. J Diabetes Res 2017; 2017: 6494795. https://www.hindawi.com/journals/jdr/2017/6494795/.
Google Scholar4. Galle-Treger, L, Sankaranarayanan, I, Hurrell, BP, et al. Costimulation of type-2 innate lymphoid cells by GITR promotes effector function and ameliorates type 2 diabetes. Nat Commun 2019; 10: 713. http://dx.doi.org/10.1038/s41467-019-08449-x
Google Scholar | Crossref | Medline5. Xu, H, Chen, M. Diabetic retinopathy and dysregulated innate immunity. Vision Res 2017; 139: 39–46. https://doi.org/10.1016/j.visres.2017.04.013
Google Scholar | Crossref | Medline6. Zhou, T, Hu, Z, Yang, S, et al. Role of adaptive and innate immunity in type 2 diabetes Mellitus. J Diabetes Res 2018; 2018: 1–9. https://www.hindawi.com/journals/jdr/2018/7457269/
Google Scholar7. Mahlangu, T, Dludla P, V, Nyambuya, TM, et al. A systematic review on the functional role of Th1/Th2 cytokines in type 2 diabetes and related metabolic complications. Cytokine 2020; 126: 154892. https://doi.org/10.1016/j.cyto.2019.154892
Google Scholar | Crossref | Medline8. Turner, MD, Nedjai, B, Hurst, T, et al. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta – Mol Cell Res 2014; 1843: 2563–2582. http://dx.doi.org/10.1016/j.bbamcr.2014.05.014
Google Scholar | Crossref | Medline | ISI9. Jagannathan-Bogdan, M, McDonnell, ME, Shin, H, et al. Elevated pro-inflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 2011; 186: 1162–1172. https://doi.org/10.4049/jimmunol.1002615
Google Scholar | Crossref | Medline | ISI10. Winer, S, Chan, Y, Paltser, G, et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921–929. http://dx.doi.org/10.1038/nm.2001
Google Scholar | Crossref | Medline | ISI11. Winer, S, Paltser, G, Chan, Y, et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009; 39: 2629–2635. https://doi.org/10.1002/eji.200838893
Google Scholar | Crossref | Medline | ISI12. O’Brien, PD, Hinder, LM, Rumora, AE, et al. Juvenile murine models of pre-diabetes and type 2 diabetes develop neuropathy. Dis Model Mech 2018; 11: 1–9. https://doi.org/10.1242/dmm.037374.
Google Scholar13. Sullivan, TEO, Rapp, M, Fan, X, et al. Adipose-Resident group 1 innate lymphoid cells promote obesity-associated insulin resistance article adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 2016; 45: 428–441. http://dx.doi.org/10.1016/j.immuni.2016.06.016
Google Scholar | Crossref | Medline14. Saetang, J, Sangkhathat, S. Role of innate lymphoid cells in obesity and metabolic disease (Review). Mol Med REPORTS 2018; 17: 1403–1412. https://dx.doi.org/10.3892%2Fmmr.2017.8038
Google Scholar | Medline15. Lu, P, Ji, X, Wan, J, et al. Activity of group 2 innate lymphoid cells is associated with chronic inflammation and dysregulated metabolic homoeostasis in type 2 diabetic nephropathy. Nephropathy Scand J Immunol. 2017: 99–107. https://doi.org/10.1111/sji.12637
Google Scholar16. Mkandla, Z, Mutize, T, Dludla P, V, et al. Impaired Glc tolerance is associated with enhanced platelet-monocyte aggregation in short-term high-Fat diet-Fed mice. Nutrients 2019; 11: 1–10. https://dx.doi.org/10.3390%2Fnu11112695
Google Scholar | Crossref17. Andrikopoulos, S, Blair, AR, Deluca, N, et al. Evaluating the Glc tolerance test in mice. Am J Physiol Endocrinol Metab. 2008: 295: 1323–1332. https://doi.org/10.1152/ajpendo.90617.2008
Google Scholar | Crossref18. Lehmann, JS, Zhao, A, Sun, B, et al. Multiplex cytokine profiling of stimulated mouse splenocytes using a cytometric bead-based immunoassay platform. J Vis Exp. 2017; 129: 1–10. https://doi.org/10.3791/56440
Google Scholar19. Sullivan, GM, Feinn, R. Using effect size—or why the P value is not enough. J Grad Med Educ 2012; 4: 279–282. https://dx.doi.org/10.4300%2FJGME-D-12-00156.1.
Google Scholar | Crossref | Medline20. Mahlangu, TJ, Dludla P, V, Mxinwa, V, et al. Elevated T-helper 2 cytokine levels in high fat diet-fed C57BL/6 mice are attenuated by short-term 6-week treatment with a combination of low-dose aspirin and metformin. Cytokine 2020; 128: 154999. https://doi.org/10.1016/j.cyto.2020.154999
Google Scholar | Crossref | Medline21. Liu, F, Wang, H, Feng, W, et al. Type 1 innate lymphoid cells are associated with type 2 diabetes. Diabetes Metab 2019; 45: 341–346. https://linkinghub.elsevier.com/retrieve/pii/S1262363618301629
Google Scholar | Crossref | Medline22. Munneke, J, Björklund, A. Activated innate lymphoid cells are associated with a reduced susceptibility to graft versus host disease. Blood 2014; 124: 812–821. http://europepmc.org/abstract/MED/24855210
Google Scholar | Crossref | Medline23. Spits, H, Artis, D, Colonna, M, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145–149. http://dx.doi.org/10.1038/nri3365
Google Scholar | Crossref | Medline | ISI24. Mortha, A, Burrows, K. Cytokine networks between innate lymphoid cells and myeloid cells. Front Immunol 2018; 9: 1–14. https://doi.org/10.3389/fimmu.2018.00191.
Google Scholar | Crossref | Medline25. O’Sullivan, TE, Rapp, M, Fan, X, et al. Adipose-Resident group 1 innate lymphoid cells promote obesity-associated insulin resistance. Immunity 2016; 45: 428–441. http://dx.doi.org/10.1016/j.immuni.2016.06.016
Google Scholar | Crossref | Medline26. Bénézech, C, Jackson-jones, LH. ILC2 Orchestration of local immune function in adipose tissue. Front Immunol 2019; 10: 1–6. https://doi.org/10.3389/fimmu.2019.00171
Google Scholar | Crossref | Medline27. von Moltke, J, Locksley, RM. ILC-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis. Current opinion in immunology. 2014; 31: 58–65. Available from: https://doi.org/10.1016/j.coi.2014.09.009.
Google Scholar28. Surendar, J, Frohberger, SJ, Karunakaran, I, et al. Adiponectin limits IFN-γ and IL-17 producing CD4 T Cells in obesity by restraining cell intrinsic glycolysis. Front Immunol 2019; 10: 1–17. https://doi.org/10.3389/fimmu.2019.02555
Google Scholar | Crossref | Medline29. Yang, D, Yang, W, Tian, Z, et al. Innate lymphoid cells as novel regulators of obesity and its-associated metabolic dysfunction. Obes Rev 2016; 17: 485–498. https://doi.org/10.1111/obr.12397
Google Scholar | Crossref | Medline30. Wu, D, Molofsky, AB, Liang, HE, et al. Eosinophils sustain adipose alternatively activated macrophages associated with Glc homeostasis. Science 2011; 332: 243–247. https://doi.org/10.1126/science.1201475
Google Scholar | Crossref | Medline | ISI31. Manta, C, Heupel, E, Radulovic, K, et al. CX3CR1+ macrophages Support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol 2013; 6: 177–188. http://dx.doi.org/10.1038/mi.2012.61
Google Scholar | Crossref | Medline32. Ignacio, A, Breda, CNS, Camara, NOS. Innate lymphoid cells in tissue homeostasis and diseases. World J Hepatol 2017; 9: 979–989. https://doi.org/10.4254/wjh.v9.i23.979
Google Scholar | Crossref | Medline33. Brestoff, JR, Kim, BS, Saenz, SA, et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015: 519:242–246. https://doi.org/10.1038/nature14115
Google Scholar | Crossref | Medline34. Boulenouar, S, Michelet, X, Duquette, D, et al. Adipose type one innate lymphoid cells regulate macrophage homeostasis through targeted cytotoxicity. Immunity 2017; 46: 273–286. https://doi.org/10.1016/j.immuni.2017.01.008
Google Scholar | Crossref | Medline